← Back to Search

Behavioural Intervention

Balance Training for Traumatic Brain Injury

N/A
Recruiting
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
For Traumatic Brain Injury: Be between the ages of 18 and 70
For Traumatic Brain Injury: Be able to stand unsupported for 5 minutes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will assess whether a balance training program can help people who have had traumatic brain injuries avoid falls.

Who is the study for?
This trial is for individuals aged 18-70 who have had a traumatic brain injury (TBI) at least 6 months ago, are medically stable for the past 3 months, can stand unaided for 5 minutes, and agree to follow study procedures without changing medications drastically.Check my eligibility
What is being tested?
The trial tests a balance training program using Neurocom's Balance Platform. It aims to improve anticipatory and compensatory postural responses in TBI patients through visual cues and platform oscillations over multiple sessions.See study design
What are the potential side effects?
While not explicitly listed, potential side effects may include discomfort or fatigue from balance exercises. Safety measures like harnesses and spotters are in place to minimize risks such as falls during the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old with a traumatic brain injury.
Select...
I can stand by myself for 5 minutes.
Select...
I can stand by myself for 5 minutes without support.
Select...
I am between 18 and 70 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anticipatory Postural Adjustment- Compensatory Postural Adjustment measures
Berg Balance Assessment
Fall Efficacy Scale -International
Secondary outcome measures
Center of Mass (CoM)
Center of Pressure (CoP)
Joint kinematics
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: TBI Intervention GroupExperimental Treatment1 Intervention
Participants will participate in 16 anticipatory postural adjustments (APA) and compensatory postural adjustments (CPA) training sessions using the Neurocom Balance Platform. Each session will last for 1 hour. During the APA portion, a visual cue on the front screen in the form of a countdown timer showing the remaining seconds to the onset of the upcoming perturbation. This information will allow an opportunity for the participant to adjust their posture to handle the upcoming perturbation in the best possible way and also train them to anticipate upcoming disturbances and execute corrective motor outputs. This will ensure the generation of APA in a consistent and repetitive manner. In CPA, after a 5 second pause, the platform will oscillate at 1 Hz, with a constant amplitude, in the anterior-posterior direction for 50 seconds, followed by an additional 5 second quiet period. The participant will wear a safety harness at all times and a spotter will be present at all times.
Group II: TBI Control GroupActive Control1 Intervention
No intervention is provided
Group III: Healthy ControlActive Control1 Intervention
No intervention is provided

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
174 Previous Clinical Trials
10,693 Total Patients Enrolled

Media Library

Perturbation-based Training with visual cues using Neurocom (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05268484 — N/A
Traumatic Brain Injury Research Study Groups: TBI Intervention Group, TBI Control Group, Healthy Control
Traumatic Brain Injury Clinical Trial 2023: Perturbation-based Training with visual cues using Neurocom Highlights & Side Effects. Trial Name: NCT05268484 — N/A
Perturbation-based Training with visual cues using Neurocom (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05268484 — N/A
~4 spots leftby Dec 2024